Taiwan FDA registration 469130ce1ef80059b47b316d169d0089
Liquichek Reticulocyte Control(S)
TW: 立可測網狀紅血球品管液
Taiwan·Risk Class 2·MD·BIO-RAD LABORATORIES·Registered Dec 17, 2013 – Dec 17, 2023ExpiredRegistration details
- Analysis ID
- 469130ce1ef80059b47b316d169d0089
- License Form
- Ministry of Health Medical Device Import No. 025703
- Customs Code
- DHA05602570301
Company information
- Manufacturer
- BIO-RAD LABORATORIES
- Manufacturer Country
- United States
- Authorized Representative
- Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.)
Product details
- Intended Use
- This product is used to monitor the values obtained by the automated reticular red blood cell count method.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B8625 Hematological Quality Management Mixture
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 17, 2013
- Expiry Date
- Dec 17, 2023
About this record
Access comprehensive regulatory information for Liquichek Reticulocyte Control(S) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 469130ce1ef80059b47b316d169d0089 and manufactured by BIO-RAD LABORATORIES. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices